Stirocainide

This classification denotes an antiarrhythmic agent with the molecular formula C22H34N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) LXD20TIK6Y, chemically known as cycloheptanone, 2-(phenylmethylene)-, o-(2-(bis(1-methylethyl)amino)ethyl)oxime, (e,e)- but more generally known as stirocainide, which bears US NIH Compound Identifier 9570767. European Medicines Agency schedules Stirocainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10655MIG. The term STIROCAINIDE is an International Non-Proprietary Name. STIROCAINIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule stirocainide under HS 29280090 and SITC 51486. As of Q4 2014, STIROCAINIDE remains US FDA's Preferred Term for this commodity. Stirocainide bears US NLM identifiers UMLS ID C0075263 and NCI Concept Code C72584. SMILES: O(/N=C1\CCCCC\C1=C/C1CCCCC1)CCN(C(C)C)C(C)C.